Communicable Diseases Surveillance: Additional reports

This report contains quarterly reports and data from a number of disease surveillance programs which report regularly to CDI.

Page last updated: 23 March 2012

Australian childhood immunisation coverage

Tables 1, 2 and 3 provide the latest quarterly report on childhood immunisation coverage from the Australian Childhood Immunisation Register (ACIR).

The data show the percentage of children ‘fully immunised’ at 12 months, 24 months and 5 years of age, for 3-month birth cohorts of children at the stated ages between 1 October and 31 December 2010. ‘Fully immunised’ refers to vaccines on the National Immunisation Program Schedule, but excludes rotavirus, pneumococcal conjugate, varicella, or meningococcal C conjugate vaccines, and is outlined in more detail below.

A full description of the basic methodology used can be found in Commun Dis Intell 1998;22:36–37.

The percentage of children ‘fully immunised’ at 12 months of age for Australia increased slightly by 0.4 percentage points to 91.8% (Table 1). There were no important changes in coverage for any individual vaccines due at 12 months of age or by jurisdiction.

Table 1. Percentage of children immunised at 1 year of age, preliminary results by disease and state or territory for the birth cohort 1 October to 31 December 2009; assessment date 31 March 2011

Vaccine
State or territory Aust
ACT NSW NT Qld SA Tas Vic WA
Total number of children
1,298
24,621
961
15,091
4,876
1,628
18,334
7,764
74,573
Diphtheria, tetanus, pertussis (%)
94.7
92.0
90.5
92.4
92.6
92.0
92.9
90.9
92.3
Poliomyelitis (%)
94.5
91.9
90.5
92.4
92.6
91.9
92.9
90.9
92.2
Haemophilus influenzae type b (%)
94.5
91.8
90.4
92.3
92.4
91.9
92.7
90.7
92.1
Hepatitis B (%)
93.8
91.6
90.4
92.2
92.2
91.9
92.5
90.4
91.9
Fully immunised (%)
93.5
91.5
90.4
92.1
92.1
91.8
92.3
90.3
91.8
Change in fully immunised since last quarter (%)
-0.4
+0.1
+0.8
+0.6
+0.6
+0.5
+0.5
+0.5
+0.4

Top of page

The percentage of children ‘fully immunised’ at 24 months of age for Australia increased by 0.1 percentage points to 92.3 (Table 2). There were no important changes in coverage for any individual vaccines due at 24 months of age or by jurisdiction.

Table 2. Percentage of children immunised at 2 years of age, preliminary results by disease and state or territory for the birth cohort 1 October to 31 December 2008; assessment date 31 March 2011*

Vaccine
State or territory Aust
ACT NSW NT Qld SA Tas Vic WA
Total number of children
1,259
24,941
857
15,368
4,890
1,723
18,100
7,552
74,690
Diphtheria, tetanus, pertussis (%)
95.7
94.9
95.5
94.7
94.6
96.2
95.8
93.3
95.0
Poliomyelitis (%)
95.6
94.9
95.5
94.7
94.6
96.2
95.7
93.3
94.9
Haemophilus influenzae type b (%)
95.5
95.1
95.3
94.6
94.5
95.9
95.7
93.3
95.2
Measles, mumps, rubella (%)
93.7
93.9
95.9
94.1
93.9
95.2
94.8
92.0
94.0
Hepatitis B (%)
95.0
94.5
95.3
94.2
94.3
96.0
95.3
92.8
94.5
Fully immunised (%)
92.2
92.5
94.4
92.4
92.2
94.1
93.5
89.9
92.7
Change in fully immunised since last quarter (%)
-1.3
+0.1
+0.5
-0.5
-0.5
-0.2
-0.0
-0.8
-0.0

* The 12 months age data for this cohort were published in Commun Dis Intell 2010;34(2):148.

Top of page

The percentage of children ‘fully immunised’ at 5 years of age for Australia decreased slightly by 0.2 percentage points, to sit currently at 89.2% (Table 3). There were no important changes in coverage for any individual vaccines due at 5 years of age or by jurisdiction.

Table 3. Percentage of children immunised at 5 years of age, preliminary results by disease and state or territory for the birth cohort 1 October to 31 December 2005; assessment date 31 March 2011

Vaccine
State or territory Aust
ACT NSW NT Qld SA Tas Vic WA
Total number of children
1,226
23,390
860
14,761
4,584
1,632
17,458
7,252
71,163
Diphtheria, tetanus, pertussis (%)
91.5
89.5
88.3
90.2
87.7
90.7
91.5
86.5
89.8
Poliomyelitis (%)
91.7
89.4
88.1
90.1
87.7
90.6
91.5
86.4
89.7
Measles, mumps, rubella (%)
91.2
89.3
87.9
90.1
87.4
90.6
91.3
86.4
89.6
Fully immunised (%)
91.0
88.9
87.4
89.7
87.1
90.2
91.0
85.7
89.2
Change in fully immunised since last quarter (%)
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

Figure 1 shows the trends in vaccination coverage from the first ACIR-derived published coverage estimates in 1997 to the current estimates. There is a clear trend of increasing vaccination coverage over time for children aged 12 months, 24 months and 6 years (till December 2007). This trend continued when the age of coverage calculation was changed from 6 to 5 years in March 2008, and then increased further in the previous quarter as outlined in the previous report.

Figure 1: Trends in vaccination coverage, Australia, 1997 to 31 December 2010, by age cohorts

Line chart trends described in paragraph above

Top of page

Birth cohort 1 January to 31 March

Tables 4, 5 and 6 provide the latest quarterly report on childhood immunisation coverage from the Australian Childhood Immunisation Register (ACIR).

The data show the percentage of children ‘fully immunised’ at 12 months, 24 months and 5 years of age, for 3-month birth cohorts of children at the stated ages between 1 January to 31 March 2011.

The percentage of children ‘fully immunised’ at 12 months of age for Australia increased by 1.5 percentage points to 90.3% (Table 4). There were no important changes in coverage for any individual vaccines due at 12 months of age or by jurisdiction.

Table 4. Percentage of children immunised at 1 year of age, preliminary results by disease and state or territory for the birth cohort 1 January to 31 March 2010; assessment date 30 June 2011

Vaccine
State or territory Aust
ACT NSW NT Qld SA Tas Vic WA
Total number of children
1,314
24,366
976
16,030
4,957
1,533
17,997
8,049
75,222
Diphtheria, tetanus, pertussis (%)
93.2
90.2
92.0
91.4
90.9
90.7
92.1
88.2
90.8
Poliomyelitis (%)
93.2
90.1
91.9
91.3
90.9
90.6
92.1
88.1
90.7
Haemophilus influenzae type b (%)
93.0
90.0
91.8
91.2
90.8
90.5
91.1
88.1
90.6
Hepatitis B (%)
92.6
89.8
91.9
91.0
90.7
90.4
91.8
87.8
90.5
Fully immunised (%)
92.5
89.7
91.8
91.0
90.5
90.4
91.6
87.6
90.3
Change in fully immunised since last quarter (%)
-1.0
-1.8
-1.4
-1.1
-1.6
-1.4
-0.8
-2.6
-1.4

Top of page

The percentage of children ‘fully immunised’ at 24 months of age for Australia increased by 0.1 percentage point to 92.8 (Table 5). There were no important changes in coverage for any individual vaccines due at 24 months of age or by jurisdiction.

Table 5. Percentage of children immunised at 2 years of age, preliminary results by disease and state or territory for the birth cohort 1 January to 31 March 2009; assessment date 30 June 2011*

Vaccine
State or territory Aust
ACT NSW NT Qld SA Tas Vic WA
Total number of children
1,146
24,033
971
15,660
4,956
1,569
17,519
7,813
73,667
Diphtheria, tetanus, pertussis (%)
95.3
94.6
96.0
94.9
94.7
95.8
95.6
94.1
94.9
Poliomyelitis (%)
95.3
94.6
96.0
94.8
94.7
95.8
95.6
94.1
94.9
Haemophilus influenzae type b (%)
95.1
94.9
95.5
94.8
94.5
96.2
95.5
94.1
95.1
Measles, mumps, rubella (%)
94.5
93.5
95.6
94.3
93.8
95.5
94.7
93.4
94.0
Hepatitis B (%)
94.9
94.2
95.8
94.5
94.1
95.7
95.1
93.6
94.5
Fully immunised (%)
93.1
92.1
94.0
92.9
92.4
94.5
93.4
91.8
92.8
Change in fully immunised since last quarter (%)
+0.9
-0.4
-0.4
+0.5
+0.2
+0.4
-0.2
+1.9
+0.1

* The 12 months age data for this cohort were published in Commun Dis Intell 2010;34(3):365.

Top of page

The percentage of children ‘fully immunised’ at 5 years of age for Australia increased slightly by 0.4 percentage points to 89.6% (Table 6). There were no important changes in coverage for any individual vaccines due at 5 years of age or by jurisdiction.

Table 6. Percentage of children immunised at 5 years of age, preliminary results by disease and state or territory for the birth cohort 1 January to 31 March 2006; assessment date 30 June 2011

Vaccine
State or territory Aust
ACT NSW NT Qld SA Tas Vic WA
Total number of children
1,228
23,532
902
15,480
4,755
1,630
17,305
7,735
72,567
Diphtheria, tetanus, pertussis (%)
91.5
90.1
88.8
90.8
87.4
91.2
91.6
86.6
90.1
Poliomyelitis (%)
91.4
90.1
88.8
90.7
87.4
91.2
91.5
86.6
90.0
Measles, mumps, rubella (%)
91.0
90.0
88.8
90.6
87.3
90.4
91.4
86.5
89.9
Fully immunised (%)
90.6
89.7
88.1
90.3
87.0
90.3
91.1
86.0
89.6
Change in fully immunised since last quarter (%)
-0.4
+0.8
+0.7
+0.6
-0.2
+0.1
+0.1
+0.3
+0.4

Figure 2 shows the trends in vaccination coverage from the first ACIR-derived published coverage estimates in 1997 to the current estimates. There is a clear trend of increasing vaccination coverage over time for children aged 12 months, 24 months and 6 years (till December 2007). This trend continued when the age of coverage calculation was changed from 6 to 5 years in March 2008, and then increased further in the previous quarter as outlined in the previous report.

Figure 2: Trends in vaccination coverage, Australia, 1997 to 31 March 2011, by age cohorts

Line chart trends described in paragraph above

Top of page

Birth cohort 1 April to 30 June

Tables 7, 8 and 9 provide the latest quarterly report on childhood immunisation coverage from the Australian Childhood Immunisation Register (ACIR).

The data show the percentage of children ‘fully immunised’ at 12 months, 24 months and 5 years of age, for 3-month birth cohorts of children at the stated ages between 1 April and 30 June 2011.

The percentage of children ‘fully immunised’ at 12 months of age for Australia increased by 1.8 percentage points to 92.1%, the highest level ever attained (Table 7). Important changes in coverage were seen for both Western Australia and South Australia with coverage for ‘fully immunised’, polio and DTP vaccines reaching the highest levels ever attained for these two jurisdictions.

Table 7. Percentage of children immunised at 1 year of age, preliminary results by disease and state or territory for the birth cohort 1 April to 30 June 2010; assessment date 30 September 2011

Vaccine
State or territory Aust
ACT NSW NT Qld SA Tas Vic WA
Total number of children
1,299
24,659
957
15,797
4,900
1,517
17,940
7,859
74,928
Diphtheria, tetanus, pertussis (%)
94.2
92.3
93.4
92.2
93.2
91.5
93.2
91.4
92.5
Poliomyelitis (%)
94.2
92.3
93.5
92.2
93.2
91.5
93.2
91.3
92.5
Haemophilus influenzae type b (%)
94.1
92.2
93.4
92.1
93.1
91.4
93.1
91.2
92.4
Hepatitis B (%)
94.0
92.0
93.4
92.0
93.1
91.4
92.8
90.8
92.2
Fully immunised (%)
93.6
91.9
93.3
91.8
93.0
91.3
92.7
90.8
92.1
Change in fully immunised since last quarter (%)
+1.1
+2.2
-1.5
+0.9
+2.5
+1.0
+1.1
+3.1
+1.7

Top of page

The percentage of children ‘fully immunised’ at 24 months of age for Australia did not change and remained at 92.8% (Table 8). There were no important changes in coverage for any individual vaccines due at 24 months of age or by jurisdiction.

Table 8. Percentage of children immunised at 2 years of age, preliminary results by disease and state or territory for the birth cohort 1 April to 30 June 2009; assessment date 30 September 2011*

Vaccine
State or territory Aust
ACT NSW NT Qld SA Tas Vic WA
Total number of children
1,256
24,138
1,023
15,872
4,881
1,642
17,752
7,996
74,560
Diphtheria, tetanus, pertussis (%)
96.0
94.7
96.2
95.0
95.3
95.5
95.7
94.3
95.0
Poliomyelitis (%)
95.9
94.6
96.2
94.9
95.3
95.5
95.6
94.2
95.0
Haemophilus influenzae type b (%)
96.7
95.1
96.6
95.1
95.2
96.0
95.7
94.7
95.3
Measles, mumps, rubella (%)
95.6
93.5
95.1
94.2
94.2
95.2
94.7
93.3
94.1
Hepatitis B (%)
95.7
94.3
95.8
94.5
94.8
95.3
95.1
93.7
94.6
Fully immunised (%)
94.5
92.3
93.7
93.0
93.2
94.3
93.6
91.7
92.8
Change in fully immunised since last quarter (%)
+1.4
+0.1
-0.3
+0.1
+0.8
-0.2
+0.2
-0.2
+0.0

* The 12 months age data for this cohort were published in Commun Dis Intell 2010;34(4):469.

Top of page

The percentage of children ‘fully immunised’ at 5 years of age for Australia decreased slightly by 0.3 percentage points to 89.3% (Table 9). There were no important changes in coverage for any individual vaccines due at 5 years of age or by jurisdiction.

Table 9. Percentage of children immunised at 5 years of age, preliminary results by disease and state or territory for the birth cohort 1 April to 30 June 2006; assessment date 30 September 2011

Vaccine
State or territory Aust
ACT NSW NT Qld SA Tas Vic WA
Total number of children
1,178
23,446
897
15,464
4,687
1,446
17,323
7,673
72,114
Diphtheria, tetanus, pertussis (%)
91.9
90.0
88.7
89.8
87.1
90.4
91.5
86.3
89.8
Poliomyelitis (%)
91.9
90.0
88.7
89.6
87.0
90.4
91.5
86.2
89.7
Measles, mumps, rubella (%)
91.6
89.9
88.6
89.5
87.0
90.5
91.5
86.2
89.6
Fully immunised (%)
91.3
89.5
88.4
89.2
86.6
90.2
91.1
85.6
89.3
Change in fully immunised since last quarter (%)
+0.7
-0.1
+0.3
-1.1
-0.3
-0.1
+0.0
-0.4
-0.3

Figure 3 shows the trends in vaccination coverage from the first ACIR-derived published coverage estimates in 1997 to the current estimates. There is a clear trend of increasing vaccination coverage over time for children aged 12 months, 24 months and 6 years (till December 2007). This trend continued when the age of coverage calculation was changed from 6 to 5 years in March 2008, and then increased further in the previous quarter as outlined in the previous report.

Figure 3: Trends in vaccination coverage, Australia, 1997 to 30 June 2011, by age cohorts

Line chart trends described in paragraph above

‘Fully immunised’ at 12 months of age is defined as a child having a record on the ACIR of 3 doses of a diphtheria (D), tetanus (T) and pertussis-containing (P) vaccine, 3 doses of polio vaccine, 2 or 3 doses of PRP-OMP containing Haemophilus influenzae type b (Hib) vaccine or 3 doses of any other Hib vaccine, and 2 or 3 doses of Comvax hepatitis B vaccine or 3 doses of all other hepatitis B vaccines. ‘Fully immunised’ at 24 months of age is defined as a child having a record on the ACIR of 3 or 4 doses of a DTP-containing vaccine, 3 doses of polio vaccine, 3 or 4 doses of PRP-OMP containing Hib vaccine or 4 doses of any other Hib vaccine, 3 or 4 doses of Comvax hepatitis B vaccine or 4 doses of all other hepatitis B vaccines, and 1 dose of a measles, mumps and rubella (MMR)-containing vaccine. ‘Fully immunised’ at 5 years of age is defined as a child having a record on the ACIR of 4 or 5 doses of a DTP-containing vaccine, 4 doses of polio vaccine, and 2 doses of an MMR-containing vaccine.

The National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases (NCIRS) provides commentary on the trends in ACIR data. For further information please contact NCIRS at: telephone +61 2 9845 1435, E-mail: brynleyh@chw.edu.au

Top of page

Australian Sentinel Practices Research Network

The Australian Sentinel Practices Research Network (ASPREN) is a national surveillance system that is funded by the Australian Government Department of Health and Ageing, owned and operated by the Royal Australian College of General Practitioners and directed through the Discipline of General Practice at the University of Adelaide.

The network consists of general practitioners who report presentations on a number of defined medical conditions each week. ASPREN was established in 1991 to provide a rapid monitoring scheme for infectious diseases that can alert public health officials of epidemics in their early stages as well as play a role in the evaluation of public health campaigns and research of conditions commonly seen in general practice. Electronic, web-based data collection was established in 2006.

In June 2010, ASPREN’s laboratory ILI testing was implemented, allowing for viral testing of 25% of ILI patients for a range of respiratory viruses including influenza A, influenza B and influenza A H1N1(2009).

The list of conditions is reviewed annually by the ASPREN management committee. In 2011, 4 conditions are being monitored. They include influenza-like illness (ILI), gastroenteritis and varicella infections (chickenpox and shingles). Definitions of these conditions are described in Surveillance systems reported in CDI, published in Commun Dis Intell 2011;35(1):57–58.

Reporting period 1 April to 30 June 2011

Sentinel practices contributing to ASPREN were located in all 8 jurisdictions in Australia. A total of 121 general practitioners contributed data to ASPREN in the second quarter of 2011. Each week an average of 94 general practitioners provided information to ASPREN at an average of 9,792 (range 7,412–11,608) consultations per week and an average of 122 (range 70–184) notifications per week.

ILI rates reported from 1 April to 30 June 2011 averaged 7 cases per 1,000 consultations (range 4–13 cases per 1,000 consultations). The reported rates in April, May and June 2011 (4–7 cases per 1,000 consultations; 4–7 cases per 1,000 consultations and 9–13 cases per 1,000 consultations respectively) were relatively consistent compared with rates in the same reporting period in 2010 (3–7 cases per 1,000 consultations, 7–9 cases per 1,000 consultations and 8–11 cases per 1,000 consultations respectively) (Figure 1).

Figure 1: Consultation rates for influenza-like illness, ASPREN, 1 January 2010 to 30 June 2011, by week of report

Line chart trends described in paragraph above

Top of page

ILI swab testing has continued through 2011. The most commonly reported virus during this reporting period was rhinovirus (21% of all swabs performed), with the second most common virus being influenza A H1N1(2009) (9% of all swabs performed) (Figure 2).

Figure 2: Influenza-like illness swab testing results, ASPREN, 1 January 2010 to 30 June 2011, by week of report

line and bar chart trends described in paragraph above

Top of page

From the beginning of 2011 to the end of week 26, 55 cases of influenza have been detected, the majority of these being H1N1(2009) (9% of all swabs performed) and the remainder influenza A untyped / other (3% of all swabs performed) and influenza B (5% of all swabs performed).

During this reporting period, consultation rates for gastroenteritis averaged 5 cases per 1,000 consultations (range 3–6 cases per 1,000, Figure 3). This was lower compared with rates in the same reporting period in 2010 where the average was 6 cases per 1,000 consultations (range 5–9 cases per 1,000).

Figure 3: Consultation rates for gastroenteritis, ASPREN, 1 January 2010 to 30 June 2011, by week of report

Line chart trends described in paragraph above

Top of page

Varicella infections were reported at a slightly lower rate for the second quarter of 2011 compared with the same period in 2010. From 1 April to 30 June 2011, recorded rates for chickenpox averaged 0.21 cases per 1,000 consultations (range 0–0.71 cases per 1,000 consultations, Figure 4).

Figure 4: Consultation rates for chickenpox, ASPREN, 1 January 2010 to 30 June 2011, by week of report

Line chart trends described in paragraph above

Top of page

In the second quarter of 2011, reported rates for shingles averaged 0.6 cases per 1,000 consultations (range 0.2–1 cases per 1,000 consultations, Figure 5), slightly lower than the same reporting period in 2010 where the average shingles rate was 0.7 cases per 1,000 consultations (0.3–1.3 cases per 1,000 consultations).

Figure 5: Consultation rates for shingles, ASPREN, 1 January 2010 to 30 June 2011, by week of report

Line chart trends described in paragraph above

Top of page

Reporting period 1 July to 30 September 2011

Sentinel practices contributing to ASPREN were located in all 8 jurisdictions in Australia. A total of 134 general practitioners contributed data to ASPREN in the third quarter of 2011. Each week an average of 111 general practitioners provided information to ASPREN at an average of 9,980 (range 9,229–10,031) consultations per week and an average of 259 (range 186–322) notifications per week.

ILI rates reported from 1 July to 30 September 2011 averaged 19 cases per 1,000 consultations (range 11–24 cases per 1,000 consultations). The reported rates in July, August and September 2011 (11–21 cases per 1,000 consultations, 19–24 cases per 1,000 consultations and 17–20 cases per 1,000 consultations respectively) were higher compared with rates in the same reporting period in 2010 (10–11 cases per 1,000 consultations, 9–18 cases per 1,000 consultations and 15–19 cases per 1,000 consultations respectively) (Figure 6).

Figure 6: Consultation rates for influenza-like illness, ASPREN, 1 January 2010 to 30 September 2011, by week of report

Line chart trends described in paragraph above

Top of page

ILI swab testing has continued through 2011. The most commonly reported virus during this reporting period was rhinovirus (17% of all swabs performed), with the second most common virus being influenza B (14% of all swabs performed) (Figure 7).

Figure 7: Influenza-like illness swab testing results, ASPREN, 1 January 2010 to 30 September 2011, by week of report

FLine and bar chart trends described in paragraph above

Top of page

From the beginning of 2011 to the end of week 39, 337 cases of influenza have been detected, the majority of these being influenza B (14% of all swabs performed), influenza A H1N1(2009) (13% of all swabs performed) and the remainder influenza A untyped/other (5% of all swabs performed).

During this reporting period, consultation rates for gastroenteritis averaged 5 cases per 1,000 consultations (range 4–7 cases per 1,000, Figure 8). This was lower compared to rates in the same reporting period in 2010 where the average was 6 cases per 1,000 consultations (range 5–8 cases per 1,000).

Figure 8: Consultation rates for gastroenteritis, ASPREN, 1 January 2010 to 30 September 2011, by week of report

Line chart trends described in paragraph above

Top of page

Varicella infections were reported at a slightly higher rate for the second quarter of 2011 compared with the same period in 2010. From 1 July to 30 September 2011, recorded rates for chickenpox averaged 0.4 cases per 1,000 consultations (range 0.2–0.61 cases per 1,000 consultations, Figure 9).

Figure 9: Consultation rates for chickenpox, ASPREN, 1 January 2010 to 30 September 2011, by week of report

Line chart trends described in paragraph above

Top of page

In the second quarter of 2011, reported rates for shingles averaged 0.8 cases per 1,000 consultations (range 0.5 to 1.3 cases per 1,000 consultations, Figure 10), which was relatively consistent compared with the same reporting period in 2010 where the average shingles rate was 0.8 cases per 1,000 consultations (0.3 to 1.3 cases per 1,000 consultations).

Figure 10: Consultation rates for shingles, ASPREN, 1 January 2010 to 30 September 2011, by week of report

Line chart trends described in paragraph above

Top of page

HIV and AIDS surveillance

National surveillance for HIV disease is coordinated by the Kirby Institute, in collaboration with state and territory health authorities and the Australian Government Department of Health and Ageing. Cases of HIV infection are notified to the National HIV Registry on the first occasion of diagnosis in Australia, by either the diagnosing laboratory (Australian Capital Territory, New South Wales, Tasmania, Victoria) or by a combination of laboratory and doctor sources (Northern Territory, Queensland, South Australia, Western Australia). Cases of AIDS are notified through the state and territory health authorities to the National AIDS Registry. Diagnoses of both HIV infection and AIDS are notified with the person’s date of birth and name code, to minimise duplicate notifications while maintaining confidentiality.

Tabulations of diagnoses of HIV infection and AIDS are based on data available 3 months after the end of the reporting interval indicated, to allow for reporting delay and to incorporate newly available information. More detailed information on diagnoses of HIV infection and AIDS is published in the quarterly Australian HIV Surveillance Report, and annually in ‘HIV/AIDS, viral hepatitis and sexually transmissible infections in Australia, annual surveillance report’. The reports are available from the Kirby Institute, CFI Building, Cnr Boundary and West Streets, Darlinghurst NSW 2010. Internet: http://hiv.cms.med.unsw.edu.au/ Telephone: +61 2 9385 0900. Facsimile: +61 2 9385 0920. For more information see Commun Dis Intell 2011;35(1):58.

HIV and AIDS diagnoses and deaths following AIDS reported for 1 July to 31 December 2010, are included in this issue of Communicable Diseases Intelligence (Tables 1, 2, 3 and 4).

Table 1: Number of new diagnoses of HIV infection, new diagnoses of AIDS and deaths following AIDS occurring in the period 1 July to 30 September 2010, by sex and state or territory of diagnosis

Sex
State or territory Totals for Australia
ACT NSW NT Qld SA Tas Vic WA This period 2010 This period 2009 YTD 2010 YTD 2009
HIV diagnoses Female
0
10
1
10
1
1
4
10
37
32
112
108
Male
3
80
1
46
12
4
63
13
222
241
698
691
Not reported
0
0
0
0
0
0
0
0
0
0
1
2
Total*
3
91
2
56
13
5
67
23
260
274
816
801
AIDS diagnoses Female
0
1
0
0
0
0
0
0
1
1
9
14
Male
0
6
0
3
0
0
13
4
26
38
80
103
Total*
0
7
0
3
0
0
13
4
27
39
89
117
AIDS deaths Female
0
0
0
0
0
0
0
0
0
1
1
2
Male
0
1
0
1
0
0
2
0
4
2
15
9
Total*
0
1
0
1
0
0
2
0
4
3
16
11

* Totals include people whose sex was reported as transgender.

Top of page

Table 2: Number of new diagnoses of HIV infection since the introduction of HIV antibody testing 1985, and number of new diagnoses of AIDS and deaths following AIDS since 1981, cumulative to 30 September 2010, by sex and state or territory

Sex
State or territory Aust
ACT NSW NT Qld SA Tas Vic WA
HIV diagnoses Female
38
1,039
31
390
130
22
485
291
2,426
Male
290
14,764
163
3,393
1,100
139
6,200
1,458
27,507
Not reported
0
228
0
0
0
0
22
0
250
Total*
328
16,066
194
3,792
1,231
161
6,731
1,756
30,259
AIDS diagnoses Female
10
282
6
79
32
4
127
49
589
Male
95
5,623
50
1,108
427
55
2,190
466
10,014
Total*
105
5,924
56
1,189
460
59
2,330
517
10,640
AIDS deaths Female
7
142
1
44
20
2
66
30
312
Male
73
3,610
33
684
281
34
1,461
301
6,477
Total*
80
3,763
34
730
301
36
1,536
332
6,812

* Totals include people whose sex was reported as transgender.

Top of page

Table 3: Number of new diagnoses of HIV infection, new diagnoses of AIDS and deaths following AIDS occurring in the period 1 October to 31 December 2010, by sex and state or territory of diagnosis

 
Sex
State or territory Totals for Australia
ACT NSW NT Qld SA Tas Vic WA This period 2010 This period 2009 YTD 2010 YTD 2009
HIV diagnoses Female
1
4
0
7
0
0
14
7
33
35
145
143
Male
3
58
0
55
2
2
57
17
194
226
892
917
Not reported
0
0
0
0
0
0
0
0
0
0
1
2
Total*
4
62
0
62
2
2
71
24
227
261
1043
1062
AIDS diagnoses Female
0
0
0
1
0
0
0
0
1
5
10
19
Male
0
11
1
4
0
0
13
3
32
20
112
123
Total*
0
11
1
5
0
0
13
3
33
25
122
142
AIDS deaths Female
0
0
0
0
0
0
0
0
0
0
1
2
Male
0
2
0
3
0
0
2
0
7
3
22
12
Total*
0
2
0
3
0
0
2
0
7
3
23
14

* Totals include people whose sex was reported as transgender.

Top of page

Table 4: Number of new diagnoses of HIV infection since the introduction of HIV antibody testing 1985, and number of new diagnoses of AIDS and deaths following AIDS since 1981, cumulative to 31 December 2010, by sex and state or territory

 
Sex
State or territory Aust
ACT NSW NT Qld SA Tas Vic WA
HIV diagnoses Female
39
1,043
31
397
130
22
499
298
2,459
Male
293
14,822
163
3,448
1,102
141
6,257
1,475
27,701
Not reported
0
228
0
0
0
0
22
0
250
Total*
332
16,128
194
3,854
1,233
163
6,802
1,780
30,486
AIDS diagnoses Female
10
282
6
80
32
4
127
49
590
Male
95
5,634
51
1,112
427
55
2,203
469
10,046
Total*
105
5,935
57
1,194
460
59
2,343
520
10,673
AIDS deaths Female
7
142
1
44
20
2
66
30
312
Male
73
3,612
33
687
281
34
1,463
301
6,484
Total*
80
3,765
34
733
301
36
1,538
332
6,819

* Totals include people whose sex was reported as transgender.

Top of page

Meningococcal surveillance

(Dr Monica M Lahra, The Prince of Wales Hospital, Randwick, NSW, 2031 for the Australian Gonococcal Surveillance Programme)

The reference laboratories of the Australian Meningococcal Surveillance Programme report data on the number of cases confirmed by laboratory testing using culture and by non-culture based techniques. Culture positive cases, where Neisseria meningitidis is grown from a normally sterile site or skin lesions, and non-culture based diagnoses, derived from results of nucleic acid amplification assays (NAA) and serological techniques, are defined as invasive meningococcal disease (IMD) according to Public Health Laboratory Network definitions. Data contained in quarterly reports are restricted to a description of the numbers of cases by jurisdiction and serogroup, where known. Some minor corrections to data in the Table may be made in subsequent reports if additional data are received. A full analysis of laboratory confirmed cases of IMD in each calendar year is contained in the annual reports of the Programme is published in Communicable Diseases Intelligence. For more information see Commun Dis Intell 2011;35(1):57.

Laboratory confirmed cases of invasive meningococcal disease for the period 1 July to 30 September 2011 are included in this issue of Communicable Diseases Intelligence (Table).

Table: Number of laboratory confirmed cases of invasive meningococcal disease, Australia, 1 July to 30 September 2011, by serogroup and state or territory

State or territory
Year Serogroup
A B C Y W135 ND All
Q3 YTD Q3 YTD Q3 YTD Q3 YTD Q3 YTD Q3 YTD Q3 YTD
Australian Capital Territory
11
0
0
0
5
0
0
0
0
0
0
0
0
0
5
10
0
0
1
2
0
0
0
0
0
0
0
0
1
2
New South Wales
11
0
0
11
26
0
0
1
6
2
4
4
15
18
51
10
0
0
14
35
2
4
2
2
0
2
2
4
20
47
Northern Territory
11
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Queensland
11
0
0
26
46
0
3
1
3
0
0
0
2
27
54
10
0
0
31
48
4
5
0
0
1
2
0
0
36
55
South Australia
11
0
0
6
10
0
1
0
0
0
2
0
1
6
14
10
0
0
6
16
0
0
0
1
0
0
0
0
6
17
Tasmania
11
0
0
4
6
0
1
0
0
1
3
0
0
5
10
10
0
0
0
1
0
0
0
0
0
0
0
1
0
2
Victoria
11
0
0
10
34
0
0
1
1
2
2
0
3
13
40
10
0
0
12
32
0
0
0
2
0
3
0
0
12
37
Western Australia
11
0
0
4
12
0
0
0
1
0
0
0
0
4
13
10
0
0
8
13
0
1
0
1
1
1
0
0
9
16
Total
11
0
0
61
139
0
5
3
12
5
11
4
21
73
188
10
0
0
73
147
6
10
3
6
3
8
2
5
86
176

Please Note: 2011 YTD totals have been amended to include diagnostic serology notifications.